Cargando…
Inflammatory Mediators of Platelet Activation: Focus on Atherosclerosis and COVID-19
Background: Atherosclerotic cardiovascular diseases are characterized by a dysregulated inflammatory and thrombotic state, leading to devastating complications with increased morbidity and mortality rates. Summary: In this review article, we present the available evidence regarding the impact of inf...
Autores principales: | Theofilis, Panagiotis, Sagris, Marios, Antonopoulos, Alexios S., Oikonomou, Evangelos, Tsioufis, Costas, Tousoulis, Dimitris |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539848/ https://www.ncbi.nlm.nih.gov/pubmed/34681830 http://dx.doi.org/10.3390/ijms222011170 |
Ejemplares similares
-
Inflammatory Mechanisms in COVID-19 and Atherosclerosis: Current Pharmaceutical Perspectives
por: Sagris, Marios, et al.
Publicado: (2021) -
Genetic Predisposition and Inflammatory Inhibitors in COVID-19: Where Do We Stand?
por: Sagris, Marios, et al.
Publicado: (2022) -
Factors Associated with Platelet Activation-Recent Pharmaceutical Approaches
por: Theofilis, Panagiotis, et al.
Publicado: (2022) -
Inflammatory Mechanisms Contributing to Endothelial Dysfunction
por: Theofilis, Panagiotis, et al.
Publicado: (2021) -
The Anti-Inflammatory Effect of Novel Antidiabetic Agents
por: Theofilis, Panagiotis, et al.
Publicado: (2022)